These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26544691)

  • 1. Recursive Random Lasso (RRLasso) for Identifying Anti-Cancer Drug Targets.
    Park H; Imoto S; Miyano S
    PLoS One; 2015; 10(11):e0141869. PubMed ID: 26544691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction-Based Feature Selection for Uncovering Cancer Driver Genes Through Copy Number-Driven Expression Level.
    Park H; Niida A; Imoto S; Miyano S
    J Comput Biol; 2017 Feb; 24(2):138-152. PubMed ID: 27759426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Adaptive Penalized Logistic Regression for Uncovering Biomarker Associated with Anti-Cancer Drug Sensitivity.
    Park H; Shiraishi Y; Imoto S; Miyano S
    IEEE/ACM Trans Comput Biol Bioinform; 2017; 14(4):771-782. PubMed ID: 27164605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sparse overlapping group lasso for integrative multi-omics analysis.
    Park H; Niida A; Miyano S; Imoto S
    J Comput Biol; 2015 Feb; 22(2):73-84. PubMed ID: 25629319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PredictiveNetwork: predictive gene network estimation with application to gastric cancer drug response-predictive network analysis.
    Park H; Imoto S; Miyano S
    BMC Bioinformatics; 2022 Aug; 23(1):342. PubMed ID: 35974335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data Mining Approaches for Genomic Biomarker Development: Applications Using Drug Screening Data from the Cancer Genome Project and the Cancer Cell Line Encyclopedia.
    Covell DG
    PLoS One; 2015; 10(7):e0127433. PubMed ID: 26132924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive NetworkProfiler for Identifying Cancer Characteristic-Specific Gene Regulatory Networks.
    Park H; Shimamura T; Imoto S; Miyano S
    J Comput Biol; 2018 Feb; 25(2):130-145. PubMed ID: 29053381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data.
    Piñeiro-Yáñez E; Reboiro-Jato M; Gómez-López G; Perales-Patón J; Troulé K; Rodríguez JM; Tejero H; Shimamura T; López-Casas PP; Carretero J; Valencia A; Hidalgo M; Glez-Peña D; Al-Shahrour F
    Genome Med; 2018 May; 10(1):41. PubMed ID: 29848362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapy in cancer.
    Tsimberidou AM
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1113-32. PubMed ID: 26391154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A computational method for clinically relevant cancer stratification and driver mutation module discovery using personal genomics profiles.
    Wang L; Li F; Sheng J; Wong ST
    BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S6. PubMed ID: 26099165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust Sample-Specific Stability Selection with Effective Error Control.
    Park H; Yamada M; Imoto S; Miyano S
    J Comput Biol; 2019 Mar; 26(3):202-217. PubMed ID: 30638394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sparse spectral graph analysis and its application to gastric cancer drug resistance-specific molecular interplays identification.
    Park H; Miyano S
    PLoS One; 2024; 19(7):e0305386. PubMed ID: 38968283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recursive Mahalanobis separability measure for gene subset selection.
    Mao KZ; Tang W
    IEEE/ACM Trans Comput Biol Bioinform; 2011; 8(1):266-72. PubMed ID: 20479500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GDSCTools for mining pharmacogenomic interactions in cancer.
    Cokelaer T; Chen E; Iorio F; Menden MP; Lightfoot H; Saez-Rodriguez J; Garnett MJ
    Bioinformatics; 2018 Apr; 34(7):1226-1228. PubMed ID: 29186349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weighted lasso in graphical Gaussian modeling for large gene network estimation based on microarray data.
    Shimamura T; Imoto S; Yamaguchi R; Miyano S
    Genome Inform; 2007; 19():142-53. PubMed ID: 18546512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.
    Cha S; Lee J; Shin JY; Kim JY; Sim SH; Keam B; Kim TM; Kim DW; Heo DS; Lee SH; Kim JI
    BMC Cancer; 2016 Feb; 16():170. PubMed ID: 26925973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Bioinformatics for Updating Anticancer Drug Developments and Personalized Therapeutics.
    Lu DY; Qu RX; Lu TR; Wu HY
    Rev Recent Clin Trials; 2017; 12(2):101-110. PubMed ID: 28190390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression genomics and cancer biology.
    Liu ET
    Pharmacogenomics; 2004 Dec; 5(8):1117-28. PubMed ID: 15584878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network pharmacology for cancer drug discovery: are we there yet?
    Azmi AS
    Future Med Chem; 2012 May; 4(8):939-41. PubMed ID: 22650234
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
    Kim D; Li R; Dudek SM; Ritchie MD
    J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.